Published: 4 November 2017
Author(s): Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Rinaldo Pellicano
Section: Letter to the Editor

In a recent study Negovan et al. assessed the impact of pathological and clinical predisposing factors (histological findings, concomitant drug consumption, comorbidities, symptoms, social habits, Helicobacter pylori—H. pylori infection) on severe gastro-duodenal lesions in patients on long-term low-dose aspirin and proton pump inhibitors (PPI) treatment [1]. They enrolled patients with chronic low-dose aspirin and PPI therapy referred for an upper digestive endoscopy between September 2012 and December 2015.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.